(Q46834300)

English

Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis

scientific article published on 16 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Leishmania infantum

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

author name string

Farnaz Zahedifard

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

Fereshteh Nazgouee

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

language of work or name

0 references

publication date

16 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

24

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

12

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

2169-2175

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

Leishmaniasis: current status of vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Imidazole-SDS-Zn reverse staining of proteins in gels containing or not SDS and microsequence of individual unmodified electroblotted proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Culture microtitration: a sensitive method for quantifying Leishmania infantum in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Recombinant DNA-derived leishmania proteins: from the laboratory to the field

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Clan CD cysteine peptidases of parasitic protozoa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

The host response to Leishmania infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.11.011

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/16325969

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46834300&oldid=2134015523"